The Women's Health Inquiry Project

Osteoarthritis: presentation, evidence and how national guidance shape women’s experiences

This piece is for general information and discussion only. It is not medical or legal advice.

Context and why the issue matters

Osteoarthritis is the most common joint condition in the UK. Although often described in everyday language as wear and tear, national guidance frames it as a long‑term condition involving cartilage loss, altered bone structure and low‑grade inflammation. NICE highlights that its presentation is shaped not only by age and mechanical factors but also by previous injury, hormonal change, genetics and wider determinants of health. For women, the condition frequently interacts with caring roles, mobility needs, long working days and the cumulative effect of chronic pain on daily life.

Impact of osteoarthritis

Osteoarthritis has wide‑ranging consequences that extend beyond joint structure and into mobility, employment, emotional wellbeing and social participation. NICE highlights that the condition is a major cause of pain and functional limitation, with symptoms that often fluctuate and interact with sleep, mood and fatigue. Evidence from NIHR and Versus Arthritis shows that many women describe a gradual reduction in confidence when walking, climbing stairs or managing everyday tasks, which can in turn affect work, caring responsibilities and independence.

Research also notes the less visible dimensions of impact: disrupted sleep, reduced capacity for physical activity, and the cumulative strain of persistent pain on concentration and decision‑making. These effects are shaped by comorbid conditions, socioeconomic circumstances and access to timely rehabilitation. Qualitative studies show that the emotional weight of progressive pain, especially when symptoms are misunderstood or dismissed, can lead to frustration, isolation and a sense that ordinary activities require disproportionate effort. Taken together, national evidence portrays osteoarthritis not as a narrow orthopedic issue but as a long‑term condition that influences multiple aspects of day‑to‑day life and contributes significantly to health inequality.

Presentation and what guidance says clinicians usually consider

Guidance sets out that osteoarthritis is primarily a clinical diagnosis. Adults over 45 who report activity‑related joint pain and short‑lived stiffness after rest are generally recognised as fitting the classical pattern. National recommendations emphasise that imaging is not routinely required unless symptoms are atypical or suggest an alternative diagnosis.

Clinicians are expected to assess movement, tenderness, swelling, functional limitation and the impact of pain on daily tasks. Gait, joint alignment and signs of instability are part of routine evaluation. The evidence describes a typical constellation of gradually worsening pain, reduced flexibility and sensations such as crepitus when moving the joint. Many women describe difficulty climbing stairs, rising from a seated position or gripping objects, even where radiographic changes are mild.

Differential diagnoses vary by joint but may include inflammatory arthritis, crystal arthropathy, bursitis, tendinopathies, meniscal injury or early avascular necrosis. National guidance notes that disproportionate pain, weight loss, fever or acute swelling would prompt assessment for infection or systemic disease.

What women often describe raising in research and investigations

National evidence does indicate recurring concerns about delayed recognition of early osteoarthritis symptoms, although the strength of that evidence differs by source. NICE guidance notes that osteoarthritis is a clinical diagnosis and warns that symptoms may be under‑recognised when mild or atypical. Large qualitative studies reviewed by NIHR describe many women reporting consultations in which early joint pain was attributed to ageing, stress or weight rather than explored in depth. Versus Arthritis has repeatedly highlighted that people with osteoarthritis, particularly women, often experience limited discussion of functional impact or quality of life and may feel their concerns are not fully validated.

Patterns of delay in accessing physiotherapy and variability in triage are documented across multiple sources. NIHR evidence summaries describe long waits for community musculoskeletal services in parts of England, and Versus Arthritis reports regional variation in access to conservative management. Investigations by the Parliamentary and Health Service Ombudsman and analyses by NHS England also identify inconsistency in referral thresholds and timing, although these findings are not specific to women.

Communication is a well‑established theme in musculoskeletal research. NIHR, the Royal Colleges and several large charities have noted that clinical conversations can at times focus heavily on lifestyle factors such as weight or activity, with less attention to pain severity, emotional impact or functional change. Qualitative studies have reported that some women describe feeling dismissed when symptoms fluctuate or when their level of pain does not match radiographic findings, a well‑recognised characteristic of osteoarthritis. Trauma‑aware communication is increasingly promoted across national programmes, but evaluations suggest that implementation is uneven and depends on local training and resources.

How NICE guidance frames early recognition and communication

NICE guidance sets out the baseline of what safe, proportionate recognition of osteoarthritis should involve. NG226 emphasises that the condition is a clinical diagnosis and that symptoms should be taken seriously even when imaging is mild or normal. Both NG226 and the earlier CG177 discourage attributing joint pain solely to age, stress or weight and instead call for discussion of function, sleep, mood and the wider effect on daily life.

These expectations are important because they make visible the gap described in national reviews, where women often report delays in their concerns being recognised, limited exploration of the impact of chronic pain and a narrow focus on lifestyle rather than the full picture of their symptoms. NICE promotes shared decision‑making and person‑centred communication, but evaluations suggest that implementation varies significantly between services.

How NICE positions medicines within osteoarthritis care

NICE places medicines within a broad, stepwise framework in which pharmacological options support, but do not replace, exercise‑based and behavioural interventions. NG226 describes oral paracetamol and topical non‑steroidal anti‑inflammatory drugs as commonly used for symptom relief, with oral NSAIDs considered where topical preparations are insufficient and risks are appropriately assessed. CG177 outlines similar principles and notes that weak opioids are sometimes used when other options are unsuitable, although national bodies repeatedly highlight safety concerns and the limited role of opioids in long‑term musculoskeletal pain. Evidence reviews referenced by NICE also discuss intra‑articular corticosteroid injections as an option for short‑term relief during significant flares.

Taken together, guidance depicts analgesia not as a standalone solution but as one component of a wider management approach, with attention to potential harms, comorbidity and shared decision‑making. Research shows that access, monitoring and review can be inconsistent across the NHS, which contributes to variation in how women experience pain management over time.

System watchpoints

This section highlights system patterns seen in research, guidance and investigations. It is not medical or legal advice, and it is not a checklist for your own care.

Who the evidence represents

National datasets largely reflect older adults and those who eventually reach surgical pathways. Women under 55, people living with complex or multi‑site pain and those with limited digital access are less visible in routine data. This influences how need is measured and where resources are allocated.

Digital design

The expansion of remote physiotherapy and digital triage has brought advantages but also challenges. Evaluations show reduced uptake among people with fluctuating pain, limited privacy at home, caring responsibilities or difficulty using app‑based exercise programmes.

Transitions of care

Guidance describes a pathway moving from primary assessment to conservative management and, where necessary, surgical consideration. Investigations show that many women experience long waits between these steps. Delays in physiotherapy, unclear escalation processes and variable referral thresholds remain common.

Communication and framing

A consistent theme in qualitative studies is that women report consultations where pain is reframed as lifestyle failure rather than explored in a structured way. Trauma‑aware communication is recommended in national materials but not routinely delivered.

What is improving

National MSK transformation programmes have encouraged the development of integrated multidisciplinary hubs. First‑contact physiotherapy roles are expanding, aiming to improve early assessment. Research investment into musculoskeletal conditions has grown, including studies exploring sex‑specific disease mechanisms. There is also increasing emphasis on personalised care and shared decision‑making.

Where further improvement might come from

Progress may come from consistent access to early rehabilitation, better continuity between primary and community services, greater attention to communication quality, and improved integration of musculoskeletal considerations into pregnancy, menopause and occupational health pathways. Readers are invited to contribute evidence or insight by email, without personal data.

Reflective questions

For clinicians and managers

  1. How effectively do current pathways identify early osteoarthritis in women with non‑classical or multi‑site symptoms?
  2. What processes support timely escalation when conservative measures do not reduce pain?
  3. How is functional impact assessed and reviewed over time?
  4. Do digital triage tools reflect the realities of fluctuating pain and caring responsibilities?
  5. How is communication monitored for consistency, clarity and trauma‑awareness?

For patients and the public

  1. What were your early symptoms? Were they recognised and taken seriously?
  2. How accessible was physiotherapy or occupational therapy when symptoms began?
  3. Did consultations acknowledge the effect of pain on work, mobility and caring roles?
  4. Was communication clear, collaborative and free of judgement?
  5. What information or support would have improved shared understanding?

Mandatory disclaimer

This article is for general information and discussion only. It is not medical or legal advice, nor a substitute for professional advice. To contribute evidence, ideas, or corrections, please email womenshealthproject@outlook.com. Please do not share personal data when emailing. Individual cases cannot be reviewed. This project does not offer any form of legal service and cannot assist with complaints, claims or individual advocacy.

This platform is independent and not affiliated with any law firm, regulator, inquiry or clinical body.

© 2026 Women’s Health Inquiry Project (WHIP). This article includes original analysis of material from publicly available national sources. It may not be reproduced without permission.

References

  1. NICE. Osteoarthritis: care and management. CG177. Available at: https://www.nice.org.uk/guidance/cg177
  2. NICE. Osteoarthritis in over 16s: diagnosis and management. NG226. Available at: https://www.nice.org.uk/guidance/ng226
  3. NHS England. Elective recovery and MSK transformation resources. Available at: https://www.england.nhs.uk
  4. Royal College of Physicians. National clinical guidance for musculoskeletal conditions. Available at: https://www.rcplondon.ac.uk
  5. Versus Arthritis. State of Musculoskeletal Health. Available at: https://www.versusarthritis.org
  6. NIHR Evidence. Osteoarthritis research summaries. Available at: https://evidence.nihr.ac.uk